Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Subclinical hypothyroidism: When to treat.

Azim S, Nasr C.

Cleve Clin J Med. 2019 Feb;86(2):101-110. doi: 10.3949/ccjm.86a.17053. Review.

2.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
3.

Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer: a retrospective cohort study.

Patell R, Mikhael A, Tabet M, Bena J, Berber E, Nasr C.

Endocrine. 2018 Sep;61(3):506-510. doi: 10.1007/s12020-018-1643-z. Epub 2018 Jun 15.

PMID:
29948933
4.

Reply to A. Piccardo et al, E. HindiƩ et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al.

Molenaar RJ, Sidana S, Radivoyevitch T, Gerds AT, Carraway HE, Kalaycio M, Nazha A, Adelstein DJ, Nasr C, Maciejewski JP, Majhail NS, Sekeres MA, Mukherjee S.

J Clin Oncol. 2018 Jun 20;36(18):1889-1892. doi: 10.1200/JCO.2018.78.4074. Epub 2018 May 3. No abstract available.

PMID:
29723096
5.

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.

Molenaar RJ, Sidana S, Radivoyevitch T, Advani AS, Gerds AT, Carraway HE, Angelini D, Kalaycio M, Nazha A, Adelstein DJ, Nasr C, Maciejewski JP, Majhail NS, Sekeres MA, Mukherjee S.

J Clin Oncol. 2018 Jun 20;36(18):1831-1839. doi: 10.1200/JCO.2017.75.0232. Epub 2017 Dec 18.

PMID:
29252123
6.

Chest X-ray Prior to Thyroidectomy: Is It Really Needed?

Mikhael A, Patell R, Tabet M, Bena J, Berber E, Nasr C.

World J Surg. 2018 May;42(5):1403-1407. doi: 10.1007/s00268-017-4357-0.

PMID:
29147894
7.

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.

Sakr HI, Chute DJ, Nasr C, Sturgis CD.

Diagn Pathol. 2017 Oct 3;12(1):71. doi: 10.1186/s13000-017-0661-0.

8.

Is a serum TSH measurement sufficient to monitor the treatment of primary hypothyroidism?

Nasr C.

Cleve Clin J Med. 2016 Aug;83(8):571-3. doi: 10.3949/ccjm.83a.15165. No abstract available.

9.

Insulin pumps: Great devices, but you still have to press the button.

Nasr C.

Cleve Clin J Med. 2015 Dec;82(12):843-5. doi: 10.3949/ccjm.82a.15047. No abstract available.

10.

Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology.

Aliyev A, Patel J, Brainard J, Gupta M, Nasr C, Hatipoglu B, Siperstein A, Berber E.

Surgery. 2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9.

PMID:
26454673
11.

The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.

Aliyev A, Soundararajan S, Bucak E, Gupta M, Hatipoglu B, Nasr C, Siperstein A, Berber E.

Surgery. 2015 Oct;158(4):1089-93; discussion 1093-4. doi: 10.1016/j.surg.2015.06.023. Epub 2015 Jul 23.

PMID:
26212344
12.

Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?

Kannan S, Nasr C.

Cleve Clin J Med. 2015 Mar;82(3):142-4. doi: 10.3949/ccjm.81a.13066. Review. No abstract available.

13.

CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.

Aliyev A, Gupta M, Nasr C, Hatipoglu B, Milas M, Siperstein A, Berber E.

Endocr Pract. 2015 Jul;21(7):777-81. doi: 10.4158/EP14425.OR. Epub 2015 Mar 18.

PMID:
25786552
14.

In reply.

Ching Sun GE, Kashyap SR, Nasr C.

Cleve Clin J Med. 2015 Jan;82(1):11-2. doi: 10.3949/ccjm.82c.01002. No abstract available.

15.

In reply.

Ching Sun GE, Kashyap SR, Nasr C.

Cleve Clin J Med. 2014 Dec;81(12):714-5. doi: 10.3949/ccjm.81c.12002. No abstract available.

PMID:
25452345
16.

Thyroid cancer & sarcoidosis.

Ergin AB, Nasr CE.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):239-43.

PMID:
25363225
17.

Diabetes therapy and cancer risk: where do we stand when treating patients?

Ching Sun GE, Kashyap SR, Nasr C.

Cleve Clin J Med. 2014 Oct;81(10):620-8. doi: 10.3949/ccjm.81a.13140. Review.

PMID:
25274656
18.

Tall-cell variant papillary thyroid carcinoma arising from struma ovarll.

Karagkounis G, Chute DJ, Nasr CE, Berber E.

Endocr Pract. 2014 Feb;20(2):e24-7. doi: 10.4158/EP13205.CR.

PMID:
24246339
19.

Anaplastic thyroid cancer in young patients: a contemporary review.

Li M, Milas M, Nasr C, Brainard JA, Khan MJ, Burkey BB, Scharpf J.

Am J Otolaryngol. 2013 Nov-Dec;34(6):636-40. doi: 10.1016/j.amjoto.2013.07.008. Epub 2013 Aug 29.

PMID:
23993450
20.

Glycemic control with use of insulin glargine after cardiothoracic surgery: a retrospective study.

Ergin AB, Nasr G, Yared JP, Bena J, Nasr C.

Endocr Pract. 2013 May-Jun;19(3):485-93. doi: 10.4158/EP12404.OR.

PMID:
23425653
21.

Is chronic nipple piercing associated with hyperprolactinemia?

Sun GE, Pantalone KM, Gupta M, Kennedy L, Nasr C, Constantiner M, Hamrahian AH, Hatipoglu B.

Pituitary. 2013 Sep;16(3):351-3. doi: 10.1007/s11102-012-0431-7.

PMID:
22965248
22.

Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery.

Abdelmalak B, Ibrahim M, Yared JP, Modic MB, Nasr C.

Curr Pharm Des. 2012;18(38):6204-14. Review.

PMID:
22762462
23.

Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimoto's thyroiditis.

Cheng V, Brainard J, Nasr C.

Thyroid. 2012 Jun;22(6):647-50. doi: 10.1089/thy.2011.0228. Epub 2012 May 8.

PMID:
22568399
24.

Approach to a low TSH level: patience is a virtue.

Pantalone KM, Nasr C.

Cleve Clin J Med. 2010 Nov;77(11):803-11. doi: 10.3949/ccjm.77a.10056. Review.

PMID:
21048053
25.

Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.

Milas M, Shin J, Gupta M, Novosel T, Nasr C, Brainard J, Mitchell J, Berber E, Siperstein A.

Ann Surg. 2010 Oct;252(4):643-51. doi: 10.1097/SLA.0b013e3181f5ba51.

PMID:
20881771
26.

Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.

Nasr C, Mason A, Mayberg M, Staugaitis SM, Asa SL.

J Clin Endocrinol Metab. 2006 Dec;91(12):4776-80. Epub 2006 Sep 12.

PMID:
16968791
27.

Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.

Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein A, Mehta AE, Reddy SK, Nasr C, Gupta MK.

J Clin Endocrinol Metab. 2004 Aug;89(8):3705-9.

PMID:
15292293
28.

How should I follow a patient with mildly elevated serum calcium and PTH, but no symptoms?

Wojtowicz J, Nasr C.

Cleve Clin J Med. 2003 Sep;70(9):811-3. No abstract available. Erratum in: Cleve Clin J Med. 2003 Nov;70(11):989.

PMID:
14518577

Supplemental Content

Loading ...
Support Center